Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116640100A reveals solid-phase synthesis for Fluralaner. Enhances purity and yield for veterinary drug supply chains significantly.
Novel patent CN120040456A details green synthesis of sitagliptin phosphate offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN109957585B reveals a high-efficiency ketoreductase process for chiral alcohol intermediates, offering significant cost reduction and scalable supply chain solutions.
Patent CN113549102B reveals a thiourea-free ozone/CO method for removing p-methoxyphenyl groups, offering high purity and reduced sulfur waste for API manufacturing.
Novel glycine-based synthetic route for Tigecycline API ensures high purity and reduced impurities for reliable pharmaceutical supply chains and cost efficiency.
Patent CN103773724B reveals biocatalytic route for high-purity chiral alcohol. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN105348250A reveals novel lipid-lowering compound synthesis. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN102876759A details a chemo-enzymatic NAD preparation method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107056756B reveals a method achieving 98.4% purity using cyclic amine catalysts, offering significant cost reduction and scalability for API manufacturing.
Patent CN101573330A reveals a novel stereo-selective route for trans-[18F]-FACBC precursors, offering significant cost reduction in PET tracer manufacturing and supply chain reliability.
Patent CN101993468A details a high-yield synthesis of dienogest intermediates. Discover cost-effective manufacturing strategies and supply chain advantages for hormonal APIs.
Patent CN105198863B reveals a novel crystallization method for Losartan, achieving 99.5% purity without salt conversion, offering significant cost reduction in API manufacturing.
Patent CN101090770B discloses a dual-ligand Rh-catalyzed system for asymmetric hydrogenation, delivering superior enantioselectivity and cost efficiency for API manufacturing.
Patent CN117164599A reveals a continuous three-step method for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for ADC drug production.
Patent CN114032258B reveals enzymatic route for L-butylphthalide intermediate. Offers high purity and cost efficiency for pharmaceutical supply chains.
Patent CN109438264A reveals high-yield Rh-catalyzed synthesis for indene amines. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN109438264A reveals Rhodium-catalyzed route for high-purity indenes amine. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced process for CNS drug intermediates via optimized Pd-coupling. Enhances yield and scalability for cost reduction in API manufacturing.
Discover a novel synthesis method for Tucatinib (CN115650977A) offering improved yield and purification. A reliable supplier solution for HER2 inhibitor intermediates.
Novel patent CN107698460A details mild synthesis of Schiff base potassium salt offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing.